TP53mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis-Reference-Cited by-同舟云学术

TP53mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis

Published:2013-01-09 Issue:5 Volume:160 Page:660-672
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kulasekararaj Austin G.,Smith Alexander E.¹,Mian Syed A.²,Mohamedali Azim M.¹,Krishnamurthy Pramila,Lea Nicholas C.¹,Gäken Joop²,Pennaneach Coralie³,Ireland Robin¹,Czepulkowski Barbara⁴,Pomplun Sabine³,Marsh Judith C.,Mufti Ghulam J.

Affiliation:

1. Department of Haematology; King's College Hospital; London; UK

2. Department of Haematological Medicine; King's College London; School of Medicine; London; UK

3. Department of Histopathology; King's College Hospital; London; UK

4. Department of Cytogenetics; Kings College Hospital; London; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12203/fullpdf

Reference34 articles.

1. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer;Allred;Journal of the National Cancer Institute,1993

2. Prognostic and predictive factors in breast cancer by immunohistochemical analysis;Allred;Modern Pathology,1998

3. The genetic basis of myelodysplastic syndromes;Bejar;Hematology/oncology Clinics of North America,2010

4. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;New England Journal of Medicine,2011

5. TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis;Bowen;Leukemia,2009

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation;Blood Advances;2024-02-13

2. Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications;European Journal of Haematology;2024-01-31

3. Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2023-12

4. The Pathology according to p53 Pathway;Pathobiology;2023-11-14

5. Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes;PLOS ONE;2023-09-20